Jielun Zhu is the founder of Excalipoint Therapetics. Excalipoint Therapetics has raised $69M in total funding. Latest round: Seed. Based in Shanghai, China.
Jielun Zhu is the Co-Founder, Chief Financial Officer, and Chief Business Officer of Excalipoint Therapeutics, a biotechnology company developing next-generation T-cell engager therapies. He has over 20 years of experience in healthcare and capital markets, including leadership roles at I-Mab Biopharma, Fapon Group, and Jefferies.
Full founder directory · Investor directory · Company funding database · Fundraising library